Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tegaderm(TM) Chlorhexidine Gluconate-gel (CHG) Dressing for the Prevention of Exit Site Infection in Patients Receiving Peritoneal Dialysis.

NCT06022835 is registered in ClinicalTrials.gov with National Healthcare Group, Singapore as lead sponsor.

NCT NCT06022835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06022835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tegaderm(TM) Chlorhexidine Gluconate-gel (CHG) Dressing for the Prevention of Exit Site Infection in Patients Receiving Peritoneal Dialysis.
Lead sponsor
National Healthcare Group, Singapore
Phase
Not applicable
Overall status
Completed
Start date
September 27, 2019
Completion date
July 31, 2023
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dialysis; complications, end stage renal disease on dialysis, peritoneal dialysis catheter exit site infection